IP Library Patent Application 12291723
Patent Application
App. No. 12/291,723

Water dispersible enteric coating formulation of nutraceutical and pharmaceutical dosage forms

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/291,723
Abstract

The present invention relates to formulations for use as enteric coatings. More particularly, the present invention relates to a formulation comprising a dry blend of food grade ingredients that can be readily dispersed in water. This dispersion exhibits low viscosity and can easily be coated onto solid dosage forms through spraying and the like to provide an enteric coating on the solid dosage form.

Claims (32)

1 . A dry powder formulation useful for producing a sprayable dispersion enteric coating, comprising:

a food grade shellac,

an ammonium salt, and

an anionic polymer

wherein the sprayable dispersion enteric coating at 15% solids in water has a viscosity of below 100 cps at about 22° C. when measured with a Brookfield LVT viscometer with a #1 spindle at 100 rpm.

2 . The dry powder formulation of claim 1 wherein the anionic polymer is selected from the group consisting of sodium carboxymethyl cellulose (CMC), sodium alginate and pectin.

3 . The dry powder formulation of claim 2 wherein the anionic polymer comprises sodium carboxymethyl cellulose (CMC) in an amount in the range of from about 1% to about 18% by weight of the dry powder formulation.

4 . The dry powder formulation of claim 3 wherein the anionic polymer further comprises sodium alginate in an amount in the range of from about 1% to about 7% by weight of the dry powder formulation.

5 . The dry powder formulation of claim 1 wherein the food grade shellac is Orange Dewaxed Shellac in an amount in the range of from about 20% to about 75% by weight of the dry powder formulation.

6 . The dry powder formulation of claim 1 wherein the ammonium salt of use in the dry powder formulation comprises ammonium carbonate in an amount in the range of from about 1.5% to about 9% by weight of the dry powder formulation.

7 . The dry powder formulation of claim 1 further comprising one or more plasticizers chosen from the group consisting of glycerine, mineral oil, triacetin, polyethylene glycol, glyceryl monostearate, monoacetylated triglyceride and polysorbate.

8 . The dry powder formulation of claim 1 further comprising an inorganic pigment in an amount up to about 70% by weight of the dry powder formulation.

9 . The dry powder formulation of claim 8 wherein the inorganic pigment is selected from the group consisting of titanium dioxide, talc and iron oxides.

10 . The dry powder formulation of claim 6 wherein the dry powder formulation comprises food grade shellac in the range of from about 30% to about 70 by weight, ammonium carbonate in the range of from about 1.5% to about 8% by weight, CMC in the range of from about 2% to about 12% by weight, glycerine in the range of from about 5% to about 10% by weight, talc in the range of from about 4% to about 24% by weight and TiO 2 in the range of from about 4% to about 24% by weight.

11 . An enteric coated nutraceutical or pharmaceutical comprising, a nutraceutical or pharmaceutical active ingredient, and an enteric coating wherein the enteric coating comprises:

a food grade shellac,

an ammonium salt, and

an anionic polymer.

12 . The enteric coated nutraceutical or pharmaceutical of claim 11 wherein the anionic polymer is selected from the group consisting of sodium carboxymethyl cellulose (CMC), sodium alginate and pectin.

13 . The enteric coated nutraceutical or pharmaceutical of claim 12 wherein the anionic polymer comprises sodium carboxymethyl cellulose (CMC) in an amount in the range of from about 1% to about 18% by weight of the enteric coating.

14 . The enteric coated nutraceutical or pharmaceutical of claim 11 wherein the food grade shellac is Orange Dewaxed Shellac in an amount in the range of from about 20% to about 75% by weight of the enteric coating.

15 . The enteric coated nutraceutical or pharmaceutical of claim 11 wherein the enteric coating further comprises one or more plasticizers chosen from the group consisting of glycerine, mineral oil, triacetin polyethylene glycol, glyceryl monostearate, mono acetylated triglyceride and polysorbate.

16 . The enteric coated nutraceutical or pharmaceutical of claim 11 wherein the enteric coating further comprises an inorganic pigment in an amount up to about 70% by weight of the weight of the enteric coating.

17 . A process for producing a sprayable dispersion enteric coating comprising the steps of:

dry blending a food grade shellac, an ammonium salt, an anionic polymer, one or more plasticizers chosen from glycerine, mineral oil, triacetin, polyethylene glycol, glyceryl monostearate, mono acetylated triglyceride and polysorbate, and, optionally, pigments, and detackifiers such as titanium dioxide, talc, iron oxides and natural colors together to form a dry powder formulation,

dispersing the dry powder formulation in about 50 to 70° C. hot water, and stirring the dispersed the dry powder formulation for a sufficient period of time to produce a low viscosity sprayable dispersion wherein the low viscosity sprayable dispersion at 15% solids in water has a viscosity of below 100 cps at about 22° C. when measured with a Brookfield LVT viscometer with a #1 spindle at 100 rpm.

18 . A process for producing a solid dosage form having an enteric coating comprising the steps of:

obtaining a nutraceutical or pharmaceutical active ingredient in a solid dosage form,

dry blending a food grade shellac, an ammonium salt, an anionic polymer, one or more plasticizers chosen from glycerine, mineral oil, triacetin, polyethylene glycol, glyceryl monostearate, mono acetylated triglyceride and polysorbate, and, optionally, and, optionally, pigments, and detackifiers such as titanium dioxide, talc, iron oxides and natural colors together to form a dry powder formulation,

dispersing the dry powder formulation in about 50 to 70° C. hot water,

stirring the dispersed the dry powder formulation for a sufficient period of time to produce a low viscosity sprayable dispersion wherein the low viscosity sprayable dispersion at 15% solids in water has a viscosity of below 100 cps at about 22° C. when measured with a Brookfield LTV viscometer with a #1 spindle at 100 rpm, and

spraying the low viscosity sprayable dispersion onto the nutraceutical or pharmaceutical active ingredient in a solid dosage form to produce an enteric coating on the nutraceutical or pharmaceutical active ingredient in a solid dosage form.

Assignments (6)
RELEASE OF PATENT SECURITY AGREEMENT Recorded Mar 18, 2013
From: THE BANK OF NOVA SCOTIA
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; ISP INVESTMENTS INC.; HERCULES INCORPORATED
Reel/Frame 030025/0320 →
SECURITY AGREEMENT Recorded Sep 16, 2011
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; HERCULES INCORPORATED; AQUALON COMPANY; ISP INVESTMENT INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 026918/0052 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded Sep 15, 2011
From: BANK OF AMERICA, N.A.
To: ASHLAND, INC.; ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; HERCULES INCORPORATED
Reel/Frame 026927/0247 →
SECURITY AGREEMENT Recorded Apr 14, 2010
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; HERCULES INCORPORATED
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 024225/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2009
From: DURIG, THOMAS; MALONE, DEREK RONELL; ZONG, YUDA
To: HERCULES INCORPORATED
Reel/Frame 022865/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2009
From: DURIG, THOMAS; MALONE, DEREK RONELL; ZONG, YUDA
To: HERCULES INCORPORATED
Reel/Frame 022865/0091 →